
BKR · Nasdaq
Consensus is Buy across all 21 tracked analysts, with a mean price target of $73.5. The supplied data does not provide low or high targets, so target clustering and the width of the spread cannot be measured. It also does not identify which analyst or firm is most bullish or least bullish. No attributable rating or target revisions were reported during the past week, preventing a conclusion on whether sentiment moved higher or lower. The substantive issue behind the available evidence is strategic execution: supporters appear to value Chart's broader industrial exposure and recurring-revenue potential, while the counterargument centers on higher debt, integration complexity and deleveraging. The lower FY2025 net income also leaves operating improvement as an unresolved question.